Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

10.11
BATS BZX Real-Time Price
As of 12:24pm ET
 -0.37 / -3.53%
Today’s Change
9.80
Today|||52-Week Range
18.48
-28.55%
Year-to-Date

Today’s Trading

Previous close10.48
Today’s open10.50
Day’s range10.10 - 10.65
Volume1,389,073
Average volume (3 months)1,659,396
Market cap$1.1B
Dividend yield--
Data as of 12:09pm ET, 05/05/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+28.33%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book13.22

Competitors

 Today’s
change
Today’s
% change
DBVTDBV Technologies SA-0.78-2.88%
NXTMNxStage Medical Inc-0.21-1.12%
BRLIBio-Reference Labora...-0.23-0.68%
SGMOSangamo BioSciences ...-0.62-4.84%
Data as of 12:22pm ET, 05/05/2015

Financials

Last reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Operating Officer &
Director
Gregory P. Madison
Chief Financial Officer
James F. Oliviero
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers